Douglas C. Lane & Associates’s Gilead Sciences GILD Stock Holding History

Douglas C. Lane & Associates’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$1.29M	Sell	12,725 -856	-6%	-$89.1K	0.03%	149
2015 Q3	$1.33M	Sell	13,581 -400	-3%	-$44.4K	0.04%	145
2015 Q2	$1.64M	Sell	13,981 -185	-1%	-$20.2K	0.04%	143
2015 Q1	$1.39M	Buy	14,166 +1,663	+13%	+$169K	0.04%	139
2014 Q4	$1.18M	Sell	12,503 -9	-0.1%	-$931	0.03%	137
2014 Q3	$1.33M	Buy	12,512 +4,055	+48%	+$397K	0.04%	137
2014 Q2	$701K	Buy	8,457 +1,086	+15%	+$84.5K	0.02%	150
2014 Q1	$522K	Sell	7,371 -83	-1%	-$6.51K	0.02%	158
2013 Q4	$560K	Sell	7,454 -960	-11%	-$66.8K	0.02%	153
2013 Q3	$529K	Sell	8,414 -32	-0.4%	-$1.91K	0.02%	152
2013 Q2	$433K	Buy	+8,446	New	+$440K	0.02%	158

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Douglas C. Lane & Associates's GILD Position: Q4 2015 in Review

Douglas C. Lane & Associates reduced its Gilead Sciences (GILD) stake by 6.3% in Q4 2015, selling an estimated $89.1K and leaving 12,725 shares worth $1.29M. The position accounts for 0.03% of the portfolio, ranked #149.

Douglas C. Lane & Associates first reported a position in GILD in Q2 2013 and has held it in 11 quarters since. The position peaked at $1.64M in Q2 2015. 1,628 funds tracked by Wall St. Rank hold GILD as of Q4 2015.

Douglas C. Lane & Associates held 12,725 shares of Gilead Sciences worth $1.29M as of Q4 2015.
Douglas C. Lane & Associates sold 856 Gilead Sciences shares in Q4 2015, an estimated $89.1K.
Gilead Sciences made up 0.03% of Douglas C. Lane & Associates's portfolio in Q4 2015, its #149 holding.
Douglas C. Lane & Associates first reported a position in Gilead Sciences in Q2 2013 and has held it in 11 quarters since.
Douglas C. Lane & Associates's Gilead Sciences position peaked at $1.64M in Q2 2015.
1,628 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2015.

Based on Douglas C. Lane & Associates's 13F filing for Q4 2015, filed 25 Jan 2016.